Our study uncovered that CD11b+/CD163+ M2 TAMs promote GSC maintenance and GSC-driven tumour growth through the PTN–PRPTZ1 signalling, demonstrating that PTN is a critical molecular mediator bridging TAMs and GSCs in GBM tumour microenvironment. The gene discussed is PTN; the disease is glioblastoma.